3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation (3D-PRIME)

Haukeland University Hospital

Status: Enrolling

Conditions: Mitral Regurgitation

Treatments: Diagnostic Test: Use of 3D echocardiography in patient follow-up

Study type: Observational

Funder types: Other

Identifiers

NCT04442828

106848

Details and patient eligibility

About

The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients with primary or secondary mitral regurgitation (MR)
• MR of moderate or severe degree
• 3D echocardiographic examinations of >= good spatial and temporal resolution

Exclusion criteria

• Co-existence of another valve disease of severe degree
• Inability to give informed consent

Trial design

300 participants in 2 patient groups

Primary mitral regurgitation

Description:

Patients with mitral regurgitation due to mitral valve disease

Treatment:

Diagnostic Test: Use of 3D echocardiography in patient follow-up

Secondary mitral regurgitation

Description:

Patients with mitral regurgitation due to ventricular or atrial disease

Treatment:

Diagnostic Test: Use of 3D echocardiography in patient follow-up